Skip to main content

Advertisement

Log in

Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement

  • ORIGINAL INVESTIGATION
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effect of 5-HT1B receptor stimulation on dopamine-mediated reinforcement in rats was investigated using intravenous self-administration of the selective dopamine uptake inhibitor GBR-12909 on an FR5 schedule of reinforcement. Pretreatment with the 5-HT1A/1B receptor agonist CGS-12066B (1–10 mg/kg, IP) dose-dependently reduced the self-administration of GBR-12909 (83 μg/injection) by increasing the interval between drug injections, consistent with a enhancement of the reinforcing effects of GBR-12909. Additionally, CGS-12066B pretreatment (3 mg/kg, IP) shifted the dose-effect function for GBR-12909 self-administration to the left. Pretreatment with the selective 5-HT1A receptor agonist 8-OH-DPAT (0.03– 1.0 mg/kg, SC) had no significant effect on GBR-12909 self-administration (83 μg/injection), indicating that the effect of CGS-12066B is not mediated by the 5-HT1A receptor. Finally, CGS-12066B pretreatment (1–10 mg/kg, IP) did not alter the self-administration of cocaine (0.03–0.5 mg/injection), suggesting that the simultaneous stimulation of multiple 5-HT receptor subtypes by the indirect 5-HT agonist properties of cocaine may mask the effect of 5-HT1B receptor stimulation on DA-mediated reinforcement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 5 February 1996/Final version: 20 June 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsons, L., Weiss, F. & Koob, G. Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement. Psychopharmacology 128, 150–160 (1996). https://doi.org/10.1007/s002130050120

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002130050120

Navigation